Organon OGN
NYSE OGN
$13.64 -0.03 (-0.26%)
As of: Sep 10, 2026 · 3:59 PM EDT

Organon (OGN) Other Non-Current Liabilities (2020 - 2026)

Organon (OGN) posted Other Non-Current Liabilities of $1.0 billion for Q2 2026, up 4.27% on a QoQ basis from $984.0 million in Q1 2026, and down 8.47% year-over-year from $1.1 billion in Q2 2025.

Analysis

Organon (OGN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Organon has reported Other Non-Current Liabilities for 7 years, with the latest figure at $1.0 billion in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 8.47% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 8.47% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 3.17% from the prior year.
  • Other Non-Current Liabilities was $1.0 billion for Q2 2026 at Organon, up from $984.0 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $1.1 billion in Q3 2025, with the low at $393.0 million in Q2 2023.
  • Average Other Non-Current Liabilities over 5 years is $689.1 million, with a median of $548.5 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities sank 75.42% in 2022, then jumped 137.14% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $411.0 million in 2022, then gained by 0.24% to $412.0 million in 2023, then surged by 137.14% to $977.0 million in 2024, then grew by 3.17% to $1.0 billion in 2025, then rose by 1.79% to $1.0 billion in 2026.
  • The last three Other Non-Current Liabilities figures came in at $1.0 billion (Q2 2026), $984.0 million (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 Organon 3.58 Bn 2.45 Bn 847.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Bn
Mar 31, 2026 984.00 Mn
Dec 31, 2025 1.01 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.12 Bn
Mar 31, 2025 994.00 Mn
Dec 31, 2024 977.00 Mn
Sep 30, 2024 674.00 Mn
Jun 30, 2024 548.00 Mn
Mar 31, 2024 549.00 Mn
Dec 31, 2023 412.00 Mn
Sep 30, 2023 421.00 Mn
Jun 30, 2023 393.00 Mn
Mar 31, 2023 421.00 Mn
Dec 31, 2022 411.00 Mn
Sep 30, 2022 441.00 Mn
Jun 30, 2022 448.00 Mn
Mar 31, 2022 454.00 Mn
Dec 31, 2021 463.00 Mn
Sep 30, 2021 506.00 Mn